Metabolomic Profile Predicts Development of Microalbuminuria in Individuals with Type 1 Diabetes
暂无分享,去创建一个
C. Forsblom | P. Groop | E. Ferrannini | N. Sandholm | J. Haukka | J. Cobb
[1] A. Krolewski,et al. Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383–390 , 2017, Diabetes Care.
[2] P. Cassano,et al. Erythritol is a pentose-phosphate pathway metabolite and associated with adiposity gain in young adults , 2017, Proceedings of the National Academy of Sciences.
[3] J. Bonventre,et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease , 2017, Diabetes Care.
[4] C. Gieger,et al. Metformin Effect on Nontargeted Metabolite Profiles in Patients With Type 2 Diabetes and in Multiple Murine Tissues , 2016, Diabetes.
[5] C. Gieger,et al. Metabolites of milk intake: a metabolomic approach in UK twins with findings replicated in two European cohorts , 2016, European Journal of Nutrition.
[6] T. Spector,et al. Characterizing Blood Metabolomics Profiles Associated with Self-Reported Food Intakes in Female Twins , 2016, PloS one.
[7] U. Andersson,et al. Metabolomic screening of pre-diagnostic serum samples identifies association between α- and γ-tocopherols and glioblastoma risk , 2016, Oncotarget.
[8] E. Ferrannini,et al. Prediction of Declining Renal Function and Albuminuria in Patients With Type 2 Diabetes by Metabolomics. , 2016, The Journal of clinical endocrinology and metabolism.
[9] Hyungwon Choi,et al. Plasma Metabonomic Profiling of Diabetic Retinopathy , 2016, Diabetes.
[10] Jean-Michel Poggi,et al. VSURF: An R Package for Variable Selection Using Random Forests , 2015, R J..
[11] D. Zeeuw,et al. Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus , 2014, Diabetic medicine : a journal of the British Diabetic Association.
[12] T. Meyer,et al. Uremic solutes and risk of end stage renal disease in type 2 diabetes , 2014, Kidney international.
[13] E. Boerwinkle,et al. Associations between metabolomic compounds and incident heart failure among African Americans: the ARIC Study. , 2013, American journal of epidemiology.
[14] M. Knip,et al. Incidence of type 1 diabetes in Finland. , 2013, JAMA.
[15] Fabian J Theis,et al. Metabolite profiling reveals new insights into the regulation of serum urate in humans , 2013, Metabolomics.
[16] G. Schernthaner,et al. Diabetic nephropathy: new approaches for improving glycemic control and reducing risk. , 2013, Journal of nephrology.
[17] Yu Cao,et al. Random Forest in Clinical Metabolomics for Phenotypic Discrimination and Biomarker Selection , 2013, Evidence-based complementary and alternative medicine : eCAM.
[18] J. Skupień,et al. The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end stage renal disease , 2012, Kidney international.
[19] Kimmo Kaski,et al. Metabolic diversity of progressive kidney disease in 325 patients with type 1 diabetes (the FinnDiane Study). , 2012, Journal of proteome research.
[20] Thomas Brendan Murphy,et al. Applying random forests to identify biomarker panels in serum 2D-DIGE data for the detection and staging of prostate cancer. , 2011, Journal of proteome research.
[21] T. Hankemeier,et al. Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study) , 2011, Metabolomics.
[22] K. Kinzler,et al. Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome , 2011, Proceedings of the National Academy of Sciences.
[23] J. Nicholson,et al. Dietary modulation of gut functional ecology studied by fecal metabonomics. , 2010, Journal of proteome research.
[24] Andrea Natali,et al. α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population , 2010, PloS one.
[25] Corey D. DeHaven,et al. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. , 2009, Analytical chemistry.
[26] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[27] Merlin C. Thomas,et al. The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes , 2009, Diabetes.
[28] W. Katon,et al. Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. , 2008, The American journal of managed care.
[29] Merlin C. Thomas,et al. Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). , 2005, Diabetes care.
[30] Michael Brownlee,et al. The pathobiology of diabetic complications: a unifying mechanism. , 2005, Diabetes.
[31] Monya Baker,et al. In biomarkers we trust? , 2005, Nature Biotechnology.
[32] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[33] J. García,et al. Characterization of the hca Cluster Encoding the Dioxygenolytic Pathway for Initial Catabolism of 3-Phenylpropionic Acid in Escherichia coliK-12 , 1998, Journal of bacteriology.
[34] S. Kreiner,et al. Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. , 1987, British medical journal.
[35] A. Folsom,et al. The ARIC Study , 2019 .
[36] M. Cooper,et al. Mechanisms of diabetic complications. , 2013, Physiological reviews.
[37] Andy Liaw,et al. Classification and Regression by randomForest , 2007 .
[38] M. Milburn,et al. Metabolon, Inc. , 2007, Pharmacogenomics.